-
Unity Biotechnology Inc (UBX) PT Lowered to $4 at H.C. Wainwright
-
Mizuho Reiterates Outperform Rating on Unity Biotechnology Inc (UBX)
-
UNITY Biotechnology (UBX) Reports Topline Results from the ASPIRE Phase 2b Study
-
Chardan Capital Markets Starts Unity Biotechnology Inc (UBX) at Buy
-
UNITY Biotechnology (UBX) Appoints Federico Grossi as Chief Medical Officer
-
UNITY Biotechnology (UBX) Misses Q3 EPS by 38c
-
UNITY Biotechnology (UBX) Appoints Alicia Tozier as Chief Strategy Officer

